Frazier Life Sciences vs RA Capital
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Frazier Life Sciences | RA Capital | |
|---|---|---|
| Type | Crossover fund | Venture capital |
| HQ | Palo Alto | Boston |
| Founded | 2015 | 2002 |
| Stages | Seed, Series A, Series B, Series C, Growth, Late Stage | Seed, Series A, Series B, Series C, Late Stage |
| Sectors | Biotech | Biotech, Medical Devices |
| AUM | $7B | $16.4B |
| Tracked investments | 141 | 233 |
| Exits (acquired/public) | 4 | 3 |
| Led rounds on record | — | 4 |
| Dated deals, last 24 mo | 1 | 11 |
Shared portfolio · 12
AlentisBluejay TherapeuticsCidara TherapeuticsHalda TherapeuticsHilleVaxKalvistaSierra OncologyVaxcyteAngitia BioCarmot TherapeuticsDiagonal TherapeuticsPhathom
Frequently asked questions
- Do Frazier Life Sciences and RA Capital invest together?
- Yes — Frazier Life Sciences and RA Capital appear together in 12 tracked portfolio companies, including Alentis, Bluejay Therapeutics, Cidara Therapeutics, Halda Therapeutics, HilleVax.